NCT06967389View on ClinicalTrials.gov

Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

June 12, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions
Obesity and OverweightObese AdolescentsWeight ManagementWeight LossCardiovascular Disease Risk Factor
Interventions
DRUG

Ozempic®

The study medication will be given in accordance with standard of care dosing schedule.

Trial Locations (1)

40506

RECRUITING

University of Kentucky, Lexington

All Listed Sponsors
lead

John Bauer

OTHER